Strikingly, adiponectin was profoundly (negatively) correlated with various indicators of the serum levels of VLDL, namely the serum levels of apolipoprotein B (apoB) in total VLDL, as well as the serum levels of TC, FC, TG, and PL in VLDL subclasses 1–4 (with the exception of serum levels of FC in VLDL subclass 2) in healthy males, but neither in healthy females nor in females or males with MS (Figure 1 and Table S3). Here, ADIPOQ is linked to myeloid sarcoma.